ActoGeniX
Latest round
- Series B
Last raised
- Apr 2013
Total raised
- $52M
Investors
- 9
About ActoGeniX
ActoGeniX is a biopharmaceutical company. It focuses on the development and commercialization of biological drugs in Europe and the United States.
Who invested in ActoGeniX
9 investors across 6 rounds
See all investors in ActoGeniX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ActoGeniX
Who invested in ActoGeniX?
ActoGeniX has 9 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ActoGeniX raised?
ActoGeniX has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did ActoGeniX last raise money?
ActoGeniX's most recent round on record is a Series B, in Apr 2013.
What does ActoGeniX do?
ActoGeniX is a biopharmaceutical company.
Where is ActoGeniX headquartered?
ActoGeniX is headquartered in Belgium.
Which VCs invest in companies like ActoGeniX?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at ActoGeniX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ActoGeniX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.